Effects of raloxifene hydrochloride on the endometrium of postmenopausal women

American Journal of Obstetrics and Gynecology

Volumn 177, Issue 6, 1997, Pages 1458-1464

  Boss, S M ^a   Huster, W J ^a   Neild, J A ^a   Glant, M D ^a   Eisenhut, C C ^a   Draper, M W ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Endometrium; Estrogen; Postmenopausal women; Raloxifene

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN RECEPTOR; MEDROXYPROGESTERONE ACETATE; RALOXIFENE;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0031445808     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(97)70091-7     Document Type: Article

References (24)

1. SR. Cummings Evaluating the benefits and risks of postmenopausal hormone therapy Am J Med 91 Suppl 5B 1991 145 185
2. D Grady SM Rubin DB Petitti CS Fox D Black B Ettinger Hormone therapy to prevent disease and prolong life in postmenopausal women Ann Intern Med 117 1992 1016 1037
3. LA Brinton RN Hoover Estrogen replacement therapy and endometrial cancer risk: unresolved issues Obstet Gynecol 81 1993 265 271
4. FE van Leeuwen J Benraadt JWW Coebergh LA Kiemeney CH Gimbrere R Otter Risk of endometrial cancer after tamoxifen treatment of breast cancer Lancet 343 1994 448 454
5. DM Wolf VG Jordan Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancer Gynecol Oncol 45 1992 118 128
6. RP Kedar TH Bourne TJ Powles WP Collins SE Ashley DO Cosgrove Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial Lancet 343 1994 1318 1321
7. LJ Black M Sato ER Rowley DE Magee A Bekele DCRF Williams Raloxifene (LY139481 HCl) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats J Clin Invest 93 1994 63 69
8. M Sato AL Glasebrook HU. Bryant Raloxifene: a selective estrogen receptor modulator J Bone Miner Metab 12 Suppl 2 1994 S9 S20
9. RF Kauffman HU Bryant Selective estrogen receptor modulators Drug News Perspect 8 1995 531 539
10. MA Miller BS Katzenellenbogen Characterization and quantitation of antiestrogen binding sites in estrogen receptor-positive and -negative human breast cancer cell lines Cancer Res 43 1983 3094 3100
11. 4th ed RJ Kurman Blaustein's pathology of the female genital tract 1994 Springer-Verlag New York
12. RW Noyes AT Hertig J Rock Dating the endometrial biopsy Fertil Steril 1 1950 3 25
13. JM. McBride The normal post-menopausal endometrium Br J Obstet Gynaecol 61 1954 691 697
14. Morphological changes induced by exogenous gestagens in normal human endometrium G Dallenbach-Hellwag Functional morphologic changes in female sex organs induced by exogenous hormones 1980 Springer Verlag New York 95 100
15. CH Buckley H Fox Biopsy pathology of the endometrium 1989 Raven Press New York 47 55
16. MW Draper DE Flowers WJ Huster JA Neild KD Harper C. Amaud A controlled trial of raloxifene (LY139481) HCI: impact on bone turnover and serum lipid profile in healthy, postmenopausal women J Bone Miner Res 11 1996 835 842
17. E Johannisson RA Parker B-M Landgren E Diczfalusy Morphometric analysis of the human endometrium in relation to peripheral hormone levels Fertil Steril 38 1982 564 571
18. TG Stovall GJ Photopulos WM Poston FW Ling LG Sandles Pipelle endometrial sampling in patients with known endometrial carcinoma Obstet Gynecol 77 1991 954 956
19. M Glant C Eisenhut S Boss M Draper A scale for assessing postmenopausal endometrial proliferation in response to potential or known selective estrogen receptor modulators [abstract] Am J Clin Pathol 104 1995 341 342
20. RJ Landis ER Heyman CG Loch Average partial association in three-way contingency tables: a review and discussion of alternative tests Int Stat Rev 46 1978 237 254
21. RB D'Agostino J Massaro H Kwan H Cabral Strategies for dealing with multiple-treatment comparisons in confirmatory clinical trials Drug Info J 27 1993 625 641
22. R Fuchs-Young MK Rippy FA Dorr LL Short AL Glasebrook JD Termine Raloxifene diminishes the uterotrophic effects of tamoxifen in treated ovariectomized rats [abstract] Breast Cancer Res Treat 32 1994 199
23. C Szego S Roberts Steroid action and interactions in uterine metabolism Recent Prog Horm Res 8 1953 419 468
24. WJ Huster SM Boss MD GIant CC Eisenhut JA Neild MW Draper Raloxifene does not cause endometrial proliferation in postmenopausal women [abstract] J Soc Gynecol Invest Suppl 3 1996 142A